A large Swedish trial finds that AI-assisted mammography detects more breast cancers and reduces future diagnosis rates compared to standard practices.
Key Details
- 1MASAI trial included more than 105,000 women in Sweden between 2021-2022.
- 2AI-supported mammography led to a 12% reduction in subsequent breast cancer diagnoses.
- 3Trial compared AI triage/detection to the standard two-radiologist double reading.
- 4AI was developed/trained on over 200,000 exams from more than 10 countries.
- 5Implementation should be cautious, with monitoring and validated AI tools.
- 6Published in The Lancet; lead author is Dr. Kristina Lång from Lund University.
Why It Matters
This is one of the first randomized controlled trials providing robust evidence that AI can enhance breast cancer screening programs, potentially improving early detection and reducing radiologist workload. These findings could accelerate responsible clinical adoption of AI in mammography.
Source
Radiology Business
Related News
•Radiology Business
UCLA Review Evaluates Breast AI for Early Cancer Detection
A UCLA-led review analyzes current evidence for AI tools in screening mammography, focusing on their capability to detect interval cancers.
•Radiology Business
Vara's AI Gains World's First Approval for Radiologist-Free Mammogram Triage
Vara has secured the world's first regulatory approval for an AI tool that autonomously classifies certain mammograms as normal, bypassing radiologist review.
•AuntMinnie
Deep Learning on DBT Enhances Five-Year Breast Cancer Risk Prediction
A longitudinal DBT-based deep learning model outperformed conventional mammography and clinical models for five-year breast cancer risk prediction.